glp-1 drugs and lupus Medications for Arthritis & Autoimmune Disease Do SGLT2 and GLP-1 therapies
Description
Exploring the relationship between Efpeglenatide dose and cardiovascular outcomes in type 2 diabetes: insights from the AMPLITUDE-O trial
This likely reflects the glucagon receptor activation increasing sympathetic tone and thermogenesis, the same mechanism that drives the additional metabolic benefits
Most GLP-1 Medications Correlated With a Lower Likelihood of Anxiety and Depression Diagnoses
These precautions stem from early safety signals, including spontaneous reports, enzyme elevations, and case studies [26, 27]
J.BallardE
